Small bowel is the sole site of involvement in approximately 30% of patients with Crohn's disease. This video interview summarizes the clinical features and highlights monitoring and treatment characteristics of this specific patient population.

Watch Dr Krisztina Gecse's interview with Prof Jimmy K. Limdi about her main talk on 'Masterclass: Optimal management of small bowel Crohn’s disease'.

Dr Krisztina Gecse

Dr Gecse is a Consultant Gastroenterologist in the Amsterdam University Medical Center in the Netherlands, primarily engaged in inflammatory bowel diseases. She completed her specialization training at the University of Szeged in Hungary and at the Academic Medical Center in Amsterdam. Dr Gecse received international awards such as the Ray Clouse Prize by the Rome Foundation (USA) and the “Rising Star Award” from United European Gastroenterology (UEG). She chaired the clinical research committee of the European Crohn’s Colitis Organization (ECCO) and is currently the president-elect of International Bowel Ultrasound Group (IBUS). She has published in Nature Reviews Gastroenterology and Hepatology, Lancet Gastroenterology and Hepatology, Gut, Gastroenterology and Journal of Crohn’s and Colitis.

Prof Jimmy K. Limdi

Jimmy Limdi is a Consultant Gastroenterologist and Head of the Inflammatory Bowel Disease Section at Northern Care Alliance NHS Foundation Trust (NE Sector) and Professor of Clinical Gastroenterology at the Manchester Academic Health Sciences Centre, University of Manchester. He is also Hon. Professor at the Manchester Metropolitan University and Deputy Director of Research & Innovation at the Northern Care Alliance NHS Foundation Trust, Manchester.

Jimmy qualified in 1993 and completed postgraduate training in Internal Medicine and Gastroenterology in Yorkshire and Manchester, followed by a period of research at the ICMS, Barts and The London, and University College Hospitals, London and a Visiting Fellowship at Boston University and Harvard, Boston, USA. His clinical research interests in IBD include diet, gut permeability and nutriceuticals, early diagnosis and outcomes, IBD therapeutics, IBD in older persons, neuromotility in IBD exercise and IBD, dysplasia in IBD and women’s health related issues in IBD.

He is a Principal and Chief Investigator to several IBD studies, is Associate editor of the Inflammatory Bowel Diseases journal and Therapeutic Advances in Gastroenterology, holds Editorial board and peer review appointments with leading gastroenterology journals and has published and lectured widely in the field. He has participated in several national and international peer review processes, Delphi panels and co-authored national and international IBD guidelines. He is currently a member of the BSG IBD Committee, BSG IBD section representative to the BSG Education Committee and previously BSG representative to the Association of Colo-Proctologists of GB&I and the BSG Food and Function CRG. He was the UK National Representative at the American College of Gastroenterology (ACG) between 2012 and 2021.